| SC 13D/A | 2024-03-06 | RA CAPITAL MANAGEMENT, L.P. | 89bio, Inc. | 14,254,298 | 14.8% | EDGAR |
| SC 13G/A | 2024-02-14 | BIOTECHNOLOGY VALUE FUND L P | 89bio, Inc. | 3,973,784 | 4.2% | EDGAR |
| SC 13G/A | 2024-02-14 | Cormorant Asset Management, LP | 89bio, Inc. | 0 | - | EDGAR |
| SC 13G/A | 2024-02-14 | Deep Track Capital, LP | 89bio, Inc. | 2,000,000 | 2.1% | EDGAR |
| SC 13G | 2024-02-14 | RTW INVESTMENTS, LP | 89bio, Inc. | 5,578,931 | 6.0% | EDGAR |
| SC 13G/A | 2024-02-13 | SUVRETTA CAPITAL MANAGEMENT, LLC | 89bio, Inc. | 4,888,434 | 5.2% | EDGAR |
| SC 13G/A | 2024-02-12 | JANUS HENDERSON GROUP PLC | 89bio, Inc. | 8,915,141 | 9.6% | EDGAR |
| SC 13G/A | 2024-02-12 | JANUS HENDERSON GROUP PLC | 89bio, Inc. | 10,081,258 | 10.8% | EDGAR |
| SC 13G/A | 2024-02-07 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 89bio, Inc. | 4,225,000 | 4.5% | EDGAR |
| SC 13G | 2024-01-29 | BlackRock Inc. | 89bio, Inc. | 5,454,196 | 5.9% | EDGAR |
| SC 13G | 2024-01-24 | STATE STREET CORP | 89bio, Inc. | - | 5.8% | EDGAR |
| SC 13D/A | 2023-12-13 | RA CAPITAL MANAGEMENT, L.P. | 89bio, Inc. | 12,875,855 | 13.6% | EDGAR |
| SC 13G | 2023-10-30 | SUVRETTA CAPITAL MANAGEMENT, LLC | 89bio, Inc. | 4,808,374 | 6.4% | EDGAR |
| SC 13D/A | 2023-08-11 | RA CAPITAL MANAGEMENT, L.P. | 89bio, Inc. | 12,874,814 | 16.7% | EDGAR |
| SC 13D/A | 2023-03-30 | RA CAPITAL MANAGEMENT, L.P. | 89bio, Inc. | 12,876,898 | 18.0% | EDGAR |
| SC 13D/A | 2023-03-24 | ORBIMED ADVISORS LLC | 89bio, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2023-02-14 | Longitude Capital Partners III, LLC | 89bio, Inc. | 1,210,527 | 2.6% | EDGAR |
| SC 13G/A | 2023-02-14 | BIOTECHNOLOGY VALUE FUND L P | 89bio, Inc. | 1,904,636 | 3.6% | EDGAR |
| SC 13G/A | 2023-02-14 | GREAT POINT PARTNERS LLC | 89bio, Inc. | 700,000 | 1.4% | EDGAR |
| SC 13G/A | 2023-02-14 | JANUS HENDERSON GROUP PLC | 89bio, Inc. | 2,709,519 | 5.6% | EDGAR |